Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDNA CareDx	$20.70 -1.2%	$18.55	$10.96 ▼ $23.24	$1.08B	2.49	872,029 shs	450,671 shs
INNV InnovAge	$7.96 -2.6%	$8.35	$2.84 ▼ $10.69	$1.11B	0.49	216,425 shs	274,475 shs
PNTG The Pennant Group	$31.46 +1.2%	$31.53	$21.73 ▼ $35.00	$1.09B	1.28	189,938 shs	168,717 shs
SBC SBC Medical Group	$3.20 -2.4%	$3.87	$2.97 ▼ $5.75	$336.45M	0.61	162,817 shs	91,943 shs

7 Stocks to Ride The A.I. Megaboom

We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDNA CareDx	-3.72%	-5.52%	+13.05%	+9.35%	+36.45%
INNV InnovAge	-4.33%	-3.75%	+4.60%	+2.31%	+175.43%
PNTG The Pennant Group	+0.51%	+2.18%	+6.07%	+8.78%	+17.65%
SBC SBC Medical Group	-3.32%	-5.33%	-28.41%	-29.82%	+3.56%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDNA CareDx	$20.70 -1.2%	$18.55	$10.96 ▼ $23.24	$1.08B	2.49	872,029 shs	450,671 shs
INNV InnovAge	$7.96 -2.6%	$8.35	$2.84 ▼ $10.69	$1.11B	0.49	216,425 shs	274,475 shs
PNTG The Pennant Group	$31.46 +1.2%	$31.53	$21.73 ▼ $35.00	$1.09B	1.28	189,938 shs	168,717 shs
SBC SBC Medical Group	$3.20 -2.4%	$3.87	$2.97 ▼ $5.75	$336.45M	0.61	162,817 shs	91,943 shs

7 Stocks to Ride The A.I. Megaboom

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDNA CareDx	-3.72%	-5.52%	+13.05%	+9.35%	+36.45%
INNV InnovAge	-4.33%	-3.75%	+4.60%	+2.31%	+175.43%
PNTG The Pennant Group	+0.51%	+2.18%	+6.07%	+8.78%	+17.65%
SBC SBC Medical Group	-3.32%	-5.33%	-28.41%	-29.82%	+3.56%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDNA CareDx	2.00	Hold	$25.00	20.77% Upside
INNV InnovAge	1.67	Reduce	$7.00	-12.06% Downside
PNTG The Pennant Group	2.88	Moderate Buy	$37.00	17.61% Upside
SBC SBC Medical Group	2.33	Hold	$8.50	165.63% Upside

Current Analyst Ratings Breakdown

Latest SBC, CDNA, INNV, and PNTG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/29/2026	CDNA CareDx	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$26.00 ➝ $28.00
4/24/2026	INNV InnovAge	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/13/2026	PNTG The Pennant Group	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$34.00 ➝ $36.00
3/27/2026	SBC SBC Medical Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
3/6/2026	SBC SBC Medical Group	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$8.00
3/2/2026	PNTG The Pennant Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
3/2/2026	PNTG The Pennant Group	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$39.00 ➝ $41.00
2/27/2026	CDNA CareDx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D)
2/25/2026	CDNA CareDx	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$25.00 ➝ $26.00
2/25/2026	CDNA CareDx	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$18.00 ➝ $21.00
2/23/2026	INNV InnovAge	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$5.00 ➝ $7.00

(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDNA CareDx	$379.80M	2.82	$0.01 per share	3,217.98	$6.07 per share	3.41
INNV InnovAge	$853.70M	1.27	N/A	N/A	$1.76 per share	4.52
PNTG The Pennant Group	$947.71M	1.16	$1.30 per share	24.27	$10.82 per share	2.91
SBC SBC Medical Group	$173.61M	1.89	$0.51 per share	6.27	$2.57 per share	1.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDNA CareDx	-$21.35M	-$0.16	N/A	69.00	N/A	-2.01%	-2.65%	-1.96%	N/A
INNV InnovAge	-$30.31M	$0.05	159.23	23.41	N/A	0.71%	2.60%	1.23%	N/A
PNTG The Pennant Group	$29.58M	$0.83	37.90	24.02	2.13	3.12%	10.10%	4.32%	5/6/2026 (Estimated)
SBC SBC Medical Group	$50.99M	$0.49	6.53	6.15	N/A	29.37%	20.76%	15.67%	5/14/2026 (Estimated)

Latest SBC, CDNA, INNV, and PNTG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2026	Q1 2026	SBC SBC Medical Group	$0.10	N/A	N/A	N/A	$41.66 million	N/A
5/6/2026	Q1 2026	PNTG The Pennant Group	$0.31	N/A	N/A	N/A	$280.75 million	N/A
5/5/2026	Q3 2026	INNV InnovAge	$0.06	-$0.22	-$0.28	-$0.22	$234.35 million	$251.94 million
4/28/2026	Q1 2026	CDNA CareDx	$0.11	$0.34	+$0.23	$0.05	$102.03 million	$117.70 million
3/27/2026	Q4 2025	SBC SBC Medical Group	$0.13	$0.14	+$0.01	$0.14	$45.19 million	$39.57 million
2/25/2026	Q4 2025	PNTG The Pennant Group	$0.31	$0.34	+$0.03	$0.24	$275.20 million	$289.32 million
2/24/2026	Q4 2025	CDNA CareDx	$0.24	$0.12	-$0.12	-$0.08	$102.76 million	$108.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDNA CareDx	N/A	N/A	N/A	N/A	N/A
INNV InnovAge	N/A	N/A	N/A	N/A	N/A
PNTG The Pennant Group	N/A	N/A	N/A	N/A	N/A
SBC SBC Medical Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDNA CareDx	N/A	3.40	3.07
INNV InnovAge	0.24	1.26	1.26
PNTG The Pennant Group	0.45	1.14	1.14
SBC SBC Medical Group	0.13	3.78	3.74

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CDNA CareDx	N/A
INNV InnovAge	12.26%
PNTG The Pennant Group	85.88%
SBC SBC Medical Group	60.82%

Insider Ownership

Company	Insider Ownership
CDNA CareDx	4.40%
INNV InnovAge	1.00%
PNTG The Pennant Group	6.90%
SBC SBC Medical Group	89.47%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CDNA CareDx	740	51.66 million	49.39 million	Optionable
INNV InnovAge	2,440	135.70 million	134.34 million	Optionable
PNTG The Pennant Group	9,700	34.95 million	32.54 million	Optionable
SBC SBC Medical Group	N/A	102.58 million	10.80 million	N/A

SBC, CDNA, INNV, and PNTG Headlines

Recent News About These Companies

SBC Medical to Announce 1Q 2026 Financial Results

May 1, 2026 | globenewswire.com

Yoshiyuki Aikawa Sells 465,000 Shares of SBC Medical Group (NASDAQ:SBC) Stock

April 30, 2026 | insidertrades.com

Insider Selling: SBC Medical Group (NASDAQ:SBC) CEO Sells 465,000 Shares of Stock

April 29, 2026 | marketbeat.com

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) Short Interest Update

April 28, 2026 | marketbeat.com

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

April 27, 2026 | globenewswire.com

SBC Medical Group (NASDAQ:SBC) CEO Yoshiyuki Aikawa Sells 3,100,000 Shares

April 24, 2026 | insidertrades.com

Yoshiyuki Aikawa Sells 3,100,000 Shares of SBC Medical Group (NASDAQ:SBC) Stock

April 23, 2026 | marketbeat.com

SBC Medical Group Announces CEO Secondary Share Offering

April 23, 2026 | tipranks.com

SBC Medical Group Holdings Incorporated: Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

April 22, 2026 | finanznachrichten.de

Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

April 22, 2026 | accessnewswire.comA

SBC Medical Group stock tumbles on secondary offering pricing

April 21, 2026 | investing.com

SBC Medical Group Shares Sink After Pricing Secondary Offering

April 21, 2026 | marketwatch.com

AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session

April 21, 2026 | msn.com

SBC Medical announces pricing of 3.1M share secondary offering by selling stockholder

April 21, 2026 | msn.com

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

April 21, 2026 | financialpost.comF

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

April 19, 2026 | financialpost.comF

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

April 19, 2026 | businesswire.com

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) Sees Significant Drop in Short Interest

April 15, 2026 | marketbeat.com

SBC Medical Group Holding Insider Trading Activity | NASDAQ:SBC | Benzinga

April 12, 2026 | benzinga.com

SBC Medical (SBC): A Miss on Paper — But There’s More Behind It

April 8, 2026 | finance.yahoo.com

SBC Medical Group Holdings Incorporated

April 8, 2026 | edition.cnn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC, CDNA, INNV, and PNTG Company Descriptions

CareDx NASDAQ:CDNA

$20.70 -0.26 (-1.24%)

Closing price 05/5/2026 04:00 PM Eastern

Extended Trading

$20.60 -0.11 (-0.51%)

As of 05/5/2026 05:55 PM Eastern

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

InnovAge NASDAQ:INNV

$7.96 -0.21 (-2.57%)

Closing price 05/5/2026 04:00 PM Eastern

Extended Trading

$7.94 -0.02 (-0.24%)

As of 05/5/2026 07:58 PM Eastern

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

The Pennant Group NASDAQ:PNTG

$31.46 +0.36 (+1.16%)

Closing price 05/5/2026 04:00 PM Eastern

Extended Trading

$31.40 -0.05 (-0.17%)

As of 05/5/2026 06:48 PM Eastern

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

SBC Medical Group NASDAQ:SBC

$3.20 -0.08 (-2.44%)

Closing price 05/5/2026 04:00 PM Eastern

Extended Trading

$3.20 0.00 (0.00%)

As of 05/5/2026 07:26 PM Eastern

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SBC, CDNA, INNV, and PNTG Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SBC, CDNA, INNV, and PNTG Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SBC, CDNA, INNV, and PNTG Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC, CDNA, INNV, and PNTG Company Descriptions

CareDx NASDAQ:CDNA

InnovAge NASDAQ:INNV

The Pennant Group NASDAQ:PNTG

SBC Medical Group NASDAQ:SBC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SBC, CDNA, INNV, and PNTG Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SBC, CDNA, INNV, and PNTG Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SBC, CDNA, INNV, and PNTG Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC, CDNA, INNV, and PNTG Company Descriptions

CareDx NASDAQ:CDNA

InnovAge NASDAQ:INNV

The Pennant Group NASDAQ:PNTG

SBC Medical Group NASDAQ:SBC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools